Skip to content
sellModerate

Novo Holdings A/S sold $988k of IOBT

owner at IO Biotech, Inc.. 658,809 shares at an average of $1.50, traded Feb 9, 2024, filed Feb 13, 2024.

Warning score
42
Value
$988k
658,809 shares
Holdings after
5,088,258
-11% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    10% owner
    +12
  • Trade size
    $988k at market
    +25
  • Share of holdings sold
    Sold 11% of holdings
    +5
  • Cluster
    No other insider selling within 14 days
    0

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001209191-24-003303, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Feb 9, 2024SOpen-market sale
COMMON STOCK
-658,809$1.50$988k5,088,258Feb 13, 2024

Related signals

Other insiders at IO Biotech, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
23Weak
IOBTbuy
IO Biotech, Inc.
Heidi Hunter
director
$21k
15,000 shares
-
43Moderate
IOBTbuy 4
IO Biotech, Inc.
Qasim Iftikhar Ahmad
Chief Medical Officer
$27k
31,350 shares
-
40Moderate
IOBTbuy 4
IO Biotech, Inc.
Devin Whittemore Smith
General Counsel
$9,720
12,000 shares
+243%
40Moderate
IOBTbuy 4
IO Biotech, Inc.
Amy Sullivan
Chief Financial Officer
$8,483
10,250 shares
+14%
46Moderate
IOBTbuy 4
IO Biotech, Inc.
Mai-Britt Zocca
Chief Executive Officer
$10k
12,500 shares
+33%
39Weak
IOBTsell
IO Biotech, Inc.
Novo Holdings A/S
owner
$802k
658,809 shares
-13%
25Weak
IOBTbuy
IO Biotech, Inc.
Brian Burkavage
Chief Accounting Officer
$10k
10,000 shares
+667%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Novo Holdings A/S sold $988k of IOBT | InsiderTell